MedPath

Comparison of oxytocin low-rate infusion versus oxytocin bolus for initiating uterine contraction during cesarean delivery: A randomized, controlled, non-inferiority trial

Phase 4
Recruiting
Conditions
Pregnancy undergoing for elective Cesarean delivery under spinal anesthesia
oxytocin, oxytocin bolus, oxytocin infusion, uterine atony
postpartum hemorrhage, Cesarean section, Cesarean delivery
Registration Number
TCTR20221113003
Lead Sponsor
Khon Kaen University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
160
Inclusion Criteria

Pregnancy aged 18-40 years old, GA 37-42 weeks, ASA ll, singleton, scheduled undergoing elective Cesarean delivery under spinal anesthesia

Exclusion Criteria

Previous uterine surgery other than cesarean section, high risk of uterine atony (macrosomia, chorioamnionitis, polyhydramnios, uterine mass), high risk of postpartum hemorrhage (placenta previa or other placenta disorders, history of postpartum hemorrhage, coagulopathy, thrombocytopenia, pre-eclampsia)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adequate uterine contraction at 3 minutes after fetal delivery percentage
Secondary Outcome Measures
NameTimeMethod
terine tone at 3 minutes after fetal delivery percentage,Additional uterotonic agents after fetal delivery percentage,Estimate blood loss more than 500 ml after fetal delivery percentage,Mild adverse effects (nausea/vomiting, flushing, tachycardia) after fetal delivery until end of operation percentage,Severe adverse effects (hypotension, chest pain, EKG change) after fetal delivery until end of operation percentage
© Copyright 2025. All Rights Reserved by MedPath